Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season. [electronic resource]
Producer: 20201109Description: 265-279 p. digitalISSN:- 1179-1942
- Adolescent
- Adult
- Adverse Drug Reaction Reporting Systems
- Aged
- Belgium -- epidemiology
- Child
- Child, Preschool
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Germany -- epidemiology
- Humans
- Infant
- Influenza Vaccines -- adverse effects
- Influenza, Human -- prevention & control
- Middle Aged
- Product Surveillance, Postmarketing
- Risk Factors
- Seasons
- Spain -- epidemiology
- Vaccination -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.